Investor sues to halt Array-Pfizer deal

BOULDER — An Array BioPharma Inc. (Nasdq: ARRY) shareholder filed suit against the company Thursday alleging it misled its shareholders regarding its $11 billion acquisition offer from Pfizer Inc. (NYSE: PFE).

The complaint, filed in the U.S. District Court of Colorado by Larry Guererro, claims Array executives omitted or misrepresented information on Array’s financial forecasts and the sale process in a letter asking them to tender their shares to Pfizer.

Specifically, the suit notes Array did not include all of the line items that went into calculating its projected earnings before…